Product
PCV10
3 clinical trials
7 indications
Indication
Pneumococcal CarriageIndication
PneumoniaIndication
MeningitisIndication
Pneumococcal InfectionIndication
Streptococcus pneumoniae infectionIndication
Invasive Pneumococcal DiseaseIndication
Protection AgainstClinical trial
Determining Whether Mass Campaigns With Fractional Dose PCV10 Would Accelerate Herd Protection Against Pneumococcal Transmission in Sub-Saharan AfricaStatus: Active (not recruiting), Estimated PCD: 2023-05-31
Clinical trial
Evaluation of Persistence of Immunogenicity Following an Open-labelled, Randomized Controlled Trial Evaluating Non-inferiority of 1+1 Compared to 2+1 Dosing Schedules of 10-valent and 13-valent Pneumococcal Conjugate Vaccine in South AfricaStatus: Completed, Estimated PCD: 2022-12-01
Clinical trial
The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines (PCV10 and PCV13) on Immunogenicity and Vaccine-serotype Carriage in Kenyan InfantsStatus: Active (not recruiting), Estimated PCD: 2022-09-30